Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1957 1
1962 1
1963 1
1968 1
1972 2
1973 1
1974 1
1976 2
1977 2
1978 1
1979 3
1980 3
1981 1
1982 2
1983 2
1984 4
1985 1
1986 5
1987 3
1988 5
1989 6
1990 6
1991 4
1992 5
1993 6
1994 2
1995 11
1996 8
1997 11
1998 15
1999 16
2000 22
2001 27
2002 23
2003 25
2004 43
2005 47
2006 49
2007 54
2008 68
2009 91
2010 83
2011 88
2012 101
2013 74
2014 108
2015 124
2016 120
2017 115
2018 141
2019 158
2020 180
2021 168
2022 79
Text availability
Article attribute
Article type
Publication date

Search Results

1,896 results
Results by year
Filters applied: . Clear all
Page 1
Acute lymphoblastic leukemia.
Chang JH, Poppe MM, Hua CH, Marcus KJ, Esiashvili N. Chang JH, et al. Pediatr Blood Cancer. 2021 May;68 Suppl 2:e28371. doi: 10.1002/pbc.28371. Pediatr Blood Cancer. 2021. PMID: 33818880 Review.
KIM-1 mediates fatty acid uptake by renal tubular cells to promote progressive diabetic kidney disease.
Mori Y, Ajay AK, Chang JH, Mou S, Zhao H, Kishi S, Li J, Brooks CR, Xiao S, Woo HM, Sabbisetti VS, Palmer SC, Galichon P, Li L, Henderson JM, Kuchroo VK, Hawkins J, Ichimura T, Bonventre JV. Mori Y, et al. Among authors: chang jh. Cell Metab. 2021 May 4;33(5):1042-1061.e7. doi: 10.1016/j.cmet.2021.04.004. Cell Metab. 2021. PMID: 33951465 Free PMC article.
Spinal Cord Dose Tolerance to Stereotactic Body Radiation Therapy.
Sahgal A, Chang JH, Ma L, Marks LB, Milano MT, Medin P, Niemierko A, Soltys SG, Tomé WA, Wong CS, Yorke E, Grimm J, Jackson A. Sahgal A, et al. Among authors: chang jh. Int J Radiat Oncol Biol Phys. 2021 May 1;110(1):124-136. doi: 10.1016/j.ijrobp.2019.09.038. Epub 2019 Oct 10. Int J Radiat Oncol Biol Phys. 2021. PMID: 31606528 Free article. Review.
NEAT1 is essential for metabolic changes that promote breast cancer growth and metastasis.
Park MK, Zhang L, Min KW, Cho JH, Yeh CC, Moon H, Hormaechea-Agulla D, Mun H, Ko S, Lee JW, Jathar S, Smith AS, Yao Y, Giang NT, Vu HH, Yan VC, Bridges MC, Kourtidis A, Muller F, Chang JH, Song SJ, Nakagawa S, Hirose T, Yoon JH, Song MS. Park MK, et al. Among authors: chang jh. Cell Metab. 2021 Dec 7;33(12):2380-2397.e9. doi: 10.1016/j.cmet.2021.11.011. Cell Metab. 2021. PMID: 34879239
Infection and Rapid Transmission of SARS-CoV-2 in Ferrets.
Kim YI, Kim SG, Kim SM, Kim EH, Park SJ, Yu KM, Chang JH, Kim EJ, Lee S, Casel MAB, Um J, Song MS, Jeong HW, Lai VD, Kim Y, Chin BS, Park JS, Chung KH, Foo SS, Poo H, Mo IP, Lee OJ, Webby RJ, Jung JU, Choi YK. Kim YI, et al. Among authors: chang jh. Cell Host Microbe. 2020 May 13;27(5):704-709.e2. doi: 10.1016/j.chom.2020.03.023. Epub 2020 Apr 6. Cell Host Microbe. 2020. PMID: 32259477 Free PMC article.
Critical role of neutralizing antibody for SARS-CoV-2 reinfection and transmission.
Kim YI, Kim SM, Park SJ, Kim EH, Yu KM, Chang JH, Kim EJ, Casel MAB, Rollon R, Jang SG, Um J, Song MS, Jeong HW, Kim EG, Kim Y, Kim SY, Park JS, Park MS, Kwon GY, Yeo SG, Lee SA, Choi YJ, Jung JU, Choi YK. Kim YI, et al. Among authors: chang jh. Emerg Microbes Infect. 2021 Dec;10(1):152-160. doi: 10.1080/22221751.2021.1872352. Emerg Microbes Infect. 2021. PMID: 33407005 Free PMC article.
GDC-9545 (Giredestrant): A Potent and Orally Bioavailable Selective Estrogen Receptor Antagonist and Degrader with an Exceptional Preclinical Profile for ER+ Breast Cancer.
Liang J, Zbieg JR, Blake RA, Chang JH, Daly S, DiPasquale AG, Friedman LS, Gelzleichter T, Gill M, Giltnane JM, Goodacre S, Guan J, Hartman SJ, Ingalla ER, Kategaya L, Kiefer JR, Kleinheinz T, Labadie SS, Lai T, Li J, Liao J, Liu Z, Mody V, McLean N, Metcalfe C, Nannini MA, Oeh J, O'Rourke MG, Ortwine DF, Ran Y, Ray NC, Roussel F, Sambrone A, Sampath D, Schutt LK, Vinogradova M, Wai J, Wang T, Wertz IE, White JR, Yeap SK, Young A, Zhang B, Zheng X, Zhou W, Zhong Y, Wang X. Liang J, et al. Among authors: chang jh. J Med Chem. 2021 Aug 26;64(16):11841-11856. doi: 10.1021/acs.jmedchem.1c00847. Epub 2021 Jul 12. J Med Chem. 2021. PMID: 34251202
GEMSTONE-301: a phase III clinical trial of CS1001 as consolidation therapy in patients with locally advanced/unresectable (stage III) non-small cell lung cancer (NSCLC) who did not have disease progression after prior concurrent/sequential chemoradiotherapy.
Zhou Q, Chen M, Wu G, Chang JH, Jiang O, Cui JW, Han G, Lin Q, Fang J, Chen GY, Wu YL. Zhou Q, et al. Among authors: chang jh. Transl Lung Cancer Res. 2020 Oct;9(5):2008-2015. doi: 10.21037/tlcr-20-608. Transl Lung Cancer Res. 2020. PMID: 33209620 Free PMC article.
1,896 results